STOCK TITAN

TAT TECHNOLOGIES LTD SEC Filings

TATT NASDAQ

Welcome to our dedicated page for TAT TECHNOLOGIES SEC filings (Ticker: TATT), a comprehensive resource for investors and traders seeking official regulatory documents including 10-K annual reports, 10-Q quarterly earnings, 8-K material events, and insider trading forms.

Our SEC filing database is enhanced with expert analysis from Rhea-AI, providing insights into the potential impact of each filing on TAT TECHNOLOGIES's stock performance. Each filing includes a concise AI-generated summary, sentiment and impact scores, and end-of-day stock performance data showing the actual market reaction. Navigate easily through different filing types including 10-K annual reports, 10-Q quarterly reports, 8-K current reports, proxy statements (DEF 14A), and Form 4 insider trading disclosures.

Designed for fundamental investors and regulatory compliance professionals, our page simplifies access to critical SEC filings. By combining real-time EDGAR feed updates, Rhea-AI's analytical insights, and historical stock performance data, we provide comprehensive visibility into TAT TECHNOLOGIES's regulatory disclosures and financial reporting.

Rhea-AI Summary

TAT Technologies Ltd (TATT) filed a Form 144 notifying the proposed sale of 7,706 ordinary shares through Oppenheimer & Co. Inc., with an aggregate market value of $298,992.80. The shares represent approximately 0.07% of the 10,940,358 shares outstanding and are scheduled for sale on 09/17/2025 on NASDAQ. The filer acquired the securities on 03/06/2017 under an employee stock option plan and intends to pay cash upon exercise. The filing reports no sales by the same person in the past three months and includes the standard representation that the seller is not aware of undisclosed material adverse information.

Rhea-AI Impact
Rhea-AI Sentiment
End-of-Day
-- %
Tags
other
-
Filing
Rhea-AI Summary

TAT Technologies Ltd. filed a Form 144 notifying the proposed sale of 7,650 ordinary shares through Oppenheimer & Co. on 09/17/2025, with an aggregate market value of $296,820.00. The shares were acquired under an Employee Stock Option Plan on 05/13/2018 and will be paid in cash upon exercise. The filing lists 10,940,358 shares outstanding for the class, and discloses a prior sale by the same person of 7,311 shares on 08/14/2025 for $263,196.00. The filer certifies they are not aware of undisclosed material adverse information.

Rhea-AI Impact
Rhea-AI Sentiment
End-of-Day
-- %
Tags
other
-
Rhea-AI Summary

TAT Technologies Ltd filings show that subsidiaries of Meitav Investment House Ltd reported beneficial holdings in the issuer's ordinary shares as of September 4, 2025. The filing discloses that Meitav Investment House Ltd (through its subsidiaries) beneficially owns 1,310,650 ordinary shares, representing 10.16% of the 12,898,582 shares outstanding reported on Bloomberg. Specifically, Meitav Provident Funds & Pension Ltd holds 1,002,049 shares (7.77%), Meitav Portfolio Management Ltd holds 218,384 shares (1.69%), and Meitav Tachlit Mutual Funds Ltd holds 90,217 shares (0.70%). The reporting persons state these subsidiaries manage funds and make independent voting and investment decisions and disclaim formation of a group or beneficial ownership beyond pecuniary interest.

Rhea-AI Impact
Rhea-AI Sentiment
End-of-Day
-- %
Tags
other
Rhea-AI Summary

TAT Technologies Ltd (TATT) filed a Form 144 reporting a proposed sale of 5,000 ordinary shares through Oppenheimer & Co. Inc. on 08/29/2025 with an aggregate market value of $188,650. The shares represent a portion of the company's reported 10,940,358 outstanding shares. The filer acquired the shares on 03/06/2024 under an Employee Stock Option Plan from the issuer and intends to pay cash upon exercise. The filing indicates no securities sold in the past three months for the account and includes the standard attestation that the seller is not aware of undisclosed material adverse information.

Rhea-AI Impact
Rhea-AI Sentiment
End-of-Day
-- %
Tags
other
-
Rhea-AI Summary

TAT Technologies Ltd (TATT) filed a Form 144 notifying the proposed sale of 9,375 ordinary shares through Oppenheimer & Co. on 08/29/2025 on NASDAQ with an aggregate market value of $353,718.75. The shares represent part of an employee stock option grant acquired from the issuer on 01/09/2023 and were to be paid in cash upon exercise. The filing shows 10,940,358 shares outstanding, and the seller reports no sales in the prior three months. By signing, the seller attests not to possess undisclosed material adverse information about the issuer.

Rhea-AI Impact
Rhea-AI Sentiment
End-of-Day
-- %
Tags
other
-
Rhea-AI Summary

TAT Technologies Ltd (TATT) Form 144 notice shows a proposed sale of 6,250 ordinary shares through Oppenheimer & Co. on 08/29/2025 on NASDAQ with an aggregate market value of $235,812.50. The shares were acquired on 08/30/2021 under an employee stock option plan and will be sold for cash upon exercise. The filing also discloses three recent insider sales by Igal Zamir on 06/09/2025, 06/16/2025, and 06/18/2025 totaling 68,905 shares with gross proceeds of $1,852,226.23. The signer certifies no undisclosed material adverse information.

Rhea-AI Impact
Rhea-AI Sentiment
End-of-Day
-- %
Tags
other
Rhea-AI Summary

TAT Technologies Ltd. reported a new three-year maintenance contract with an international airline to service the GTCP331-500 auxiliary power unit used on the Boeing 777 platform. The agreement is expected to generate approximately $12 million in revenue over its term, or about $4 million per year.

The deal expands TAT’s presence on the Boeing 777 and reinforces its position in the APU maintenance, repair and overhaul (MRO) market. Management highlighted that the company’s leasing activities complement its MRO services and that strategic agreements with Honeywell are helping create additional revenue opportunities like this contract.

Rhea-AI Impact
Rhea-AI Sentiment
End-of-Day
-10.6%
Tags
current report
-
Rhea-AI Summary

TAT Technologies Ltd (TATT) filed a Form 144 notifying a proposed sale under Rule 144 of 7,311 ordinary shares through Oppenheimer & Co. Inc. on 08/14/2025 with an aggregate market value of $247,916.01. The shares were acquired on 05/13/2018 under an Employee Stock Option Plan and will be paid in cash upon exercise. The filing states there were 10,940,358 shares outstanding and reports no sales in the past three months. The filer certifies lack of undisclosed material adverse information and includes the standard Rule 144 sale disclosures.

Rhea-AI Impact
Rhea-AI Sentiment
End-of-Day
-- %
Tags
other
-
Rhea-AI Summary

Wasatch Advisors LP reported beneficial ownership of 781,216 ordinary shares of TAT Technologies Ltd, equal to 6.1% of the class. Wasatch holds sole voting power over 741,159 shares and sole dispositive power over all 781,216 shares, with no shared voting or dispositive powers. The filing states these securities are held in the ordinary course of business and were not acquired to change or influence control of the issuer. Wasatch is identified as an investment adviser organized in Delaware.

Rhea-AI Impact
Rhea-AI Sentiment
End-of-Day
-- %
Tags
other
Rhea-AI Summary

TAT Technologies Ltd. furnished a Form 6-K as a foreign private issuer for August 2025. The company submitted this report under the Securities Exchange Act of 1934 and attached a company presentation as Exhibit 99.1. The filing is primarily administrative, making the presentation publicly available.

Rhea-AI Impact
Rhea-AI Sentiment
End-of-Day
-12.38%
Tags
current report

FAQ

How many TAT TECHNOLOGIES (TATT) SEC filings are available on StockTitan?

StockTitan tracks 69 SEC filings for TAT TECHNOLOGIES (TATT), including 10-K annual reports, 10-Q quarterly reports, 8-K current reports, and Form 4 insider trading disclosures. Each filing includes AI-generated summaries, impact scoring, and sentiment analysis.

When was the most recent SEC filing for TAT TECHNOLOGIES (TATT)?

The most recent SEC filing for TAT TECHNOLOGIES (TATT) was filed on September 18, 2025.